Travere Therapeutics(TVTX) - 2018 Q4 - Earnings Call Transcript
Retrophin, Inc. (RTRX) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Chris Cline - VP, IR Eric Dube - CEO Dr. Noah Rosenberg - CMO Laura Clague - CFO Neil McFarlane - COO Dr. Bill Rote - SVP, R&D Conference Call Participants Tim Lugo - William Blair Maury Raycroft - Jefferies Joseph Schwartz - SVB Leerink Keith Tapper - BMO Capital Markets Michelle Gilson - Canaccord Genuity Lisa Bayko - JMP Securities Operator Good afternoon, ladies and gentlemen, and welcome to the Ret ...